Skip to main content

Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease

Journal of General Internal Medicine volume 29, pages 1657–1662 (2014)Cite this article

ABSTRACT

BACKGROUND

Adults with sickle cell disease (SCD) report experiencing discriminatory behavior from some healthcare providers. The impact of discrimination on health outcomes in SCD, including adherence to physician recommendations, is not known.

OBJECTIVE

Our aim was to evaluate the association between perceived discrimination from healthcare providers and nonadherence to physician recommendations among persons with SCD, and to test the potentially mediating role of patient trust.

PARTICIPANTS

Patients with SCD (age 15 years and older) participating in the Improving Patient Outcomes with Respect and Trust (IMPORT) Study.

MAIN MEASURES

Perceived discrimination from healthcare providers and reported adherence to physician recommendations were assessed by patient self-report using items from the 2001 Commonwealth Fund Health Survey. Interpersonal trust in medical professionals was assessed using the short form of the Wake Forest Trust in Medical Professionals instrument.

DESIGN

We used a cross-sectional analysis of IMPORT participant data. Multivariable Poisson regression models were used to test the independent association of discrimination with adherence and to test patient trust as a potential mediator.

KEY RESULTS

Among 273 SCD patients with complete data on all variables of interest, patients reporting experiences of discrimination in the healthcare system were 53 % more likely to also report being nonadherent to physician recommendations. Trust in medical professionals appeared to mediate the discrimination/nonadherence relationship, accounting for 50 % of the excess prevalence of nonadherence among those experiencing discrimination.

CONCLUSION

SCD patient perceptions of discriminatory experiences from healthcare providers are associated with greater nonadherence to physician recommendations, and may be a potential factor contributing to disparities in health and health quality among this patient population. Perceived discrimination appears to affect adherence behaviors through the pathway of patient trust. Improving relationships between healthcare providers and SCD patients may improve the trust that SCD patients have in medical professionals, which in turn may improve other outcomes among this underserved patient population.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

REFERENCES

  1. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the united states: national and state estimates. Am J Hematol. 2010;85(1):77–8.

    PubMed  Google Scholar 

  2. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–21.

    Article  PubMed  Google Scholar 

  3. Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics. 2006;118(3):e934–63.

    Article  PubMed  Google Scholar 

  4. Steinberg MH. Disorders of Hemoglobin: genetics, Pathophysiology, and Clinical Management. 2nd ed. New York: Cambridge University Press; 2009:826.

    Book  Google Scholar 

  5. Lanzkron S, Haywood C Jr, Fagan PJ, Rand CS. Examining the effectiveness of hydroxyurea in people with sickle cell disease. J Health Care Poor Underserved. 2010;21(1):277–86.

    Article  PubMed  Google Scholar 

  6. Candrilli SD, O’Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among medicaid enrollees with sickle cell disease. Am J Hematol. 2011;86(3):273–7.

    Article  PubMed  Google Scholar 

  7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  CAS  PubMed  Google Scholar 

  8. Maxwell K, Streetly A, Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ. 1999;318(7198):1585–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Alleyne J, Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs. 1994;19(4):725–32.

    Article  CAS  PubMed  Google Scholar 

  10. Lattimer L, Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Beach MC. Problematic hospital experiences among adult patients with sickle cell disease. J Health Care Poor Underserved. 2010;21(4):1114–23.

    PubMed Central  PubMed  Google Scholar 

  11. Haywood C Jr, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101(10):1022–33.

    PubMed  Google Scholar 

  12. Haywood C Jr, Lanzkron S, Ratanawongsa N, et al. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med. 2010;25(6):543–8.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Haywood C Jr, Lanzkron S, Ratanawongsa N, Bediako SM, Lattimer-Nelson L, Beach MC. Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. J Hosp Med. 2010;5(5):289–94.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Collins KS, Hughes DL, Doty MM, et al. Diverse Communities, Common Concerns: assessing Health Care Quality for Minority Americans. New York: The Commonwealth Fund; 2002.

    Google Scholar 

  15. Johnson RL, Saha S, Arbelaez JJ, Beach MC, Cooper LA. Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med. 2004;19(2):101–10.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Dugan E, Trachtenberg F, Hall MA. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res. 2005;5:64.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Behrens T, Taeger D, Wellmann J, Keil U. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med. 2004;43(5):505–9.

    CAS  PubMed  Google Scholar 

  18. Cummings P. Methods for estimating adjusted risk ratios. Stata J. 2009;9(2):175–96.

    Google Scholar 

  19. Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42(6):992–8.

    Article  PubMed  Google Scholar 

  20. Cummings P. The relative merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163(5):438–45.

    Article  PubMed  Google Scholar 

  21. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.

    Article  CAS  PubMed  Google Scholar 

  22. StataCorp. Stata Statistical Software: release 13. College Station: StataCorp LP; 2013.

    Google Scholar 

  23. Cuffee YL, Hargraves JL, Rosal M, et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health. 2013;103:e55–62.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Elder K, Ramamonjiarivelo Z, Wiltshire J, et al. Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health. 2012;102(12):2242–5.

    Article  PubMed  Google Scholar 

  25. Saha S, Jacobs EA, Moore RD, Beach MC. Trust in physicians and racial disparities in HIV care. AIDS Patient Care STDS. 2010;24(7):415–20.

    Article  PubMed Central  PubMed  Google Scholar 

  26. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992;146(6):1559–64.

    Article  CAS  PubMed  Google Scholar 

  28. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69–76. discussion S77-8.

    Article  CAS  PubMed  Google Scholar 

  29. Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34–44.

    Article  PubMed  Google Scholar 

  30. Balkrishnan R, Jayawant SS. Medication adherence research in populations: measurement issues and other challenges. Clin Ther. 2007;29(6):1180–3.

    Article  PubMed  Google Scholar 

  31. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2(6):757–64.

    Article  CAS  PubMed  Google Scholar 

  32. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074,90. discussion 1073.

    Article  Google Scholar 

  33. Zempsky WT. Treatment of sickle cell pain: fostering trust and justice. JAMA. 2009;302(22):2479–80.

    Article  PubMed  Google Scholar 

  34. Elander J, Beach MC, Haywood C. Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health. 2011;16(4–5):405–21.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Contributors

The authors thank all members and participants of the IMPORT study for their contributions. The full list of IMPORT investigators includes the authors, as well as the following individuals—Johns Hopkins Investigators: Tanita Woodson, Jordan Wilks, Benjamin Ajiboye, Nina Shah. Howard University Investigators: Abiodun Akintilo; Margaret Fadojutimi-Akinsiku; Patricia O’Neal, MD; Adriana Medina; Seyed- Mehdi Nouraie; John Kwagyan; Kemi Owoyemi; and Ronke Ajala.

Study data were collected and managed using REDCap electronic data capture tools hosted at Johns Hopkins University. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources.

Funders

This study was funded by a grant from the National, Heart, Lung and Blood Institute (NHLBI) (#1R01HL088511-01). Dr. Haywood’s effort was funded by a Career Development Award from the NHLBI (#1K01HL108832-01). Dr. Lanzkron’s effort was funded by a Career Development Award from the NHLBI (#K23HL083089). The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Prior Presentations

None.

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Author information

Authors and Affiliations

  1. The Johns Hopkins School of Medicine, Baltimore, MD, USA

    Carlton Haywood Jr. PhD, Sophie Lanzkron MD, John J. Strouse MD, Jennifer Haythornthwaite PhD, C. Patrick Carroll MD & Mary Catherine Beach MD

  2. The University of Maryland, Baltimore County, Baltimore County, MD, USA

    Shawn Bediako PhD

  3. The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Marie Diener-West PhD

  4. Howard University Hospital, Washington, DC, USA

    Gladys Onojobi MD

  5. The Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Berman Institute of Bioethics, 1809 Ashland Avenue Deering Hall, Room 210, Baltimore, MD, 21205, USA

    Carlton Haywood Jr. PhD & Mary Catherine Beach MD

Authors
  1. Carlton Haywood Jr. PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Lanzkron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shawn Bediako PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John J. Strouse MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jennifer Haythornthwaite PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Patrick Carroll MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marie Diener-West PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gladys Onojobi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mary Catherine Beach MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the IMPORT Investigators

Corresponding author

Correspondence to Carlton Haywood Jr. PhD.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Haywood, C., Lanzkron, S., Bediako, S. et al. Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease. J GEN INTERN MED 29, 1657–1662 (2014). https://doi.org/10.1007/s11606-014-2986-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-014-2986-7

KEY WORDS

  • sickle cell disease
  • discrimination
  • trust
  • adherence